Aspira Women's Health Inc. (AWH)
USD 0.1
(0.93%)
USD 0.1
(0.93%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 227 Thousand USD | -28.16% |
| 2022 | 316 Thousand USD | 81.61% |
| 2021 | 174 Thousand USD | 480.0% |
| 2020 | 30 Thousand USD | 20.0% |
| 2019 | 25 Thousand USD | -72.83% |
| 2018 | 92 Thousand USD | -9.8% |
| 2017 | 102 Thousand USD | 9.68% |
| 2016 | 93 Thousand USD | 6.9% |
| 2015 | 87 Thousand USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 1.00 USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 5.59 Million USD | -19.15% |
| 2004 | 6.91 Million USD | -16.64% |
| 2003 | 8.3 Million USD | 21.17% |
| 2002 | 6.85 Million USD | 76.14% |
| 2001 | 3.88 Million USD | 194.18% |
| 2000 | 1.32 Million USD | 83.1% |
| 1999 | 722 Thousand USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 236 Thousand USD | 3.96% |
| 2024 Q2 | 226 Thousand USD | -4.24% |
| 2023 Q1 | 302 Thousand USD | -4.43% |
| 2023 Q2 | 272 Thousand USD | -9.93% |
| 2023 Q3 | 301 Thousand USD | 10.66% |
| 2023 Q4 | 227 Thousand USD | -24.58% |
| 2023 FY | 227 Thousand USD | -28.16% |
| 2022 Q4 | 316 Thousand USD | 12.86% |
| 2022 FY | 316 Thousand USD | 81.61% |
| 2022 Q2 | 191 Thousand USD | 1.06% |
| 2022 Q1 | 189 Thousand USD | 8.62% |
| 2022 Q3 | 280 Thousand USD | 46.6% |
| 2021 Q3 | 137 Thousand USD | 35.64% |
| 2021 Q4 | 174 Thousand USD | 27.01% |
| 2021 FY | 174 Thousand USD | 480.0% |
| 2021 Q1 | 71 Thousand USD | 136.67% |
| 2021 Q2 | 101 Thousand USD | 42.25% |
| 2020 FY | 30 Thousand USD | 20.0% |
| 2020 Q1 | 63 Thousand USD | 152.0% |
| 2020 Q2 | 66 Thousand USD | 4.76% |
| 2020 Q3 | 45 Thousand USD | -31.82% |
| 2020 Q4 | 30 Thousand USD | -33.33% |
| 2019 FY | 25 Thousand USD | -72.83% |
| 2019 Q2 | 90 Thousand USD | -8.16% |
| 2019 Q1 | 98 Thousand USD | 6.52% |
| 2019 Q3 | 29 Thousand USD | -67.78% |
| 2019 Q4 | 25 Thousand USD | -13.79% |
| 2018 Q4 | 92 Thousand USD | -20.0% |
| 2018 Q1 | 102 Thousand USD | 0.0% |
| 2018 Q2 | 110 Thousand USD | 7.84% |
| 2018 FY | 92 Thousand USD | -9.8% |
| 2018 Q3 | 115 Thousand USD | 4.55% |
| 2017 Q3 | 155 Thousand USD | 51.96% |
| 2017 Q2 | 102 Thousand USD | 13.33% |
| 2017 FY | 102 Thousand USD | 9.68% |
| 2017 Q4 | 102 Thousand USD | -34.19% |
| 2017 Q1 | 90 Thousand USD | -3.23% |
| 2016 FY | 93 Thousand USD | 6.9% |
| 2016 Q1 | 71 Thousand USD | -18.39% |
| 2016 Q2 | 80 Thousand USD | 12.68% |
| 2016 Q3 | 92 Thousand USD | 15.0% |
| 2016 Q4 | 93 Thousand USD | 1.09% |
| 2015 Q4 | 87 Thousand USD | 7.41% |
| 2015 FY | 87 Thousand USD | 0.0% |
| 2015 Q3 | 81 Thousand USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q3 | 1.00 USD | 0.0% |
| 2014 FY | - USD | -100.0% |
| 2014 Q2 | 1.00 USD | 0.0% |
| 2014 Q4 | - USD | -100.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | 1.00 USD | 0.0% |
| 2013 FY | 1.00 USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q3 | 4.25 Million USD | -8.71% |
| 2006 FY | - USD | -100.0% |
| 2006 Q1 | 5 Million USD | -10.51% |
| 2006 Q2 | 4.66 Million USD | -6.89% |
| 2006 Q4 | - USD | -100.0% |
| 2005 Q2 | 6.54 Million USD | -6.92% |
| 2005 Q1 | 7.02 Million USD | 1.58% |
| 2005 Q3 | 6.04 Million USD | -7.55% |
| 2005 Q4 | 5.59 Million USD | -7.51% |
| 2005 FY | 5.59 Million USD | -19.15% |
| 2004 Q2 | 10.05 Million USD | 10.92% |
| 2004 FY | 6.91 Million USD | -16.64% |
| 2004 Q4 | 6.91 Million USD | -38.88% |
| 2004 Q1 | 9.06 Million USD | 9.23% |
| 2004 Q3 | 11.32 Million USD | 12.57% |
| 2003 Q2 | 7.68 Million USD | 10.66% |
| 2003 Q3 | 7.59 Million USD | -1.08% |
| 2003 Q4 | 8.3 Million USD | 9.24% |
| 2003 Q1 | 6.94 Million USD | 1.33% |
| 2003 FY | 8.3 Million USD | 21.17% |
| 2002 Q3 | 5.97 Million USD | 25.28% |
| 2002 Q1 | 4.32 Million USD | 11.31% |
| 2002 FY | 6.85 Million USD | 76.14% |
| 2002 Q4 | 6.85 Million USD | 14.7% |
| 2002 Q2 | 4.76 Million USD | 10.12% |
| 2001 Q4 | 3.88 Million USD | 1.22% |
| 2001 Q3 | 3.84 Million USD | 151.77% |
| 2001 Q2 | 1.52 Million USD | 11.06% |
| 2001 FY | 3.88 Million USD | 194.18% |
| 2001 Q1 | 1.37 Million USD | 3.93% |
| 2000 Q4 | 1.32 Million USD | -6.37% |
| 2000 Q3 | 1.41 Million USD | 0.0% |
| 2000 FY | 1.32 Million USD | 83.1% |
| 1999 FY | 722 Thousand USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -1128.089% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | 70.805% |
| Standard BioTools Inc. | 20.53 Million USD | 98.894% |
| Inotiv, Inc. | 56.1 Million USD | 99.595% |
| Prenetics Global Limited | 3.12 Million USD | 92.74% |
| Neuronetics, Inc. | 8.09 Million USD | 97.195% |
| Star Equity Holdings, Inc. | 3.42 Million USD | 93.363% |
| Castle Biosciences, Inc. | 7.94 Million USD | 97.142% |
| Psychemedics Corporation | 1.00 USD | -22699900.0% |
| RadNet, Inc. | 1.00 USD | -22699900.0% |
| Exact Sciences Corporation | 127.47 Million USD | 99.822% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 99.94% |
| iSpecimen Inc. | - USD | -Infinity% |
| OpGen, Inc. | 1.00 USD | -22699900.0% |
| Exagen Inc. | 2.87 Million USD | 92.093% |
| Bionano Genomics, Inc. | 22.89 Million USD | 99.008% |
| CareDx, Inc | 19.47 Million USD | 98.834% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 32.06 Million USD | 99.292% |
| Guardant Health, Inc. | 61.94 Million USD | 99.634% |
| Biodesix, Inc. | 1.4 Million USD | 83.786% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | 80.049% |
| Precipio, Inc. | 384 Thousand USD | 40.885% |
| Natera, Inc. | 40.75 Million USD | 99.443% |
| Fulgent Genetics, Inc. | 5.82 Million USD | 96.104% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| 23andMe Holding Co. | 12.46 Million USD | 98.179% |
| OPKO Health, Inc. | 65.69 Million USD | 99.654% |
| Personalis, Inc. | 5.66 Million USD | 95.99% |
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | 31.218% |
| T2 Biosystems, Inc. | 4.81 Million USD | 95.289% |
| Neogen Corporation | 189.26 Million USD | 99.88% |
| Myriad Genetics, Inc. | 20.1 Million USD | 98.871% |
| ICON Public Limited Company | 1.00 USD | -22699900.0% |
| NeoGenomics, Inc. | 24.15 Million USD | 99.06% |
| Star Equity Holdings, Inc. | 3.42 Million USD | 93.363% |
| MDxHealth SA | 2.77 Million USD | 91.832% |
| Prenetics Global Limited | 3.12 Million USD | 92.74% |
| Illumina, Inc. | 587 Million USD | 99.961% |
| DarioHealth Corp. | 5.06 Million USD | 95.516% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | 91.345% |
| Medpace Holdings, Inc. | 1.00 USD | -22699900.0% |
| Mainz Biomed B.V. | 613.63 Thousand USD | 63.008% |
| Trinity Biotech plc | 19.93 Million USD | 98.861% |
| Sotera Health Company | 51.98 Million USD | 99.563% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -1128.089% |